| Drug Name (select from list of drugs shown) |
| Campral (acamprosate calcium) |
|
|
|
|
|
|
| Patient Information |
| Patient Name: |
|
|
| Patient ID: |
|
|
| Patient Group No.: |
|
|
| Patient DOB: |
|
|
| Prescribing Physician |
| Physician Name: |
|
|
| Physician Phone: |
|
|
| Physician Fax: |
|
|
| Physician Address: |
|
|
| City, State, Zip: |
|
|
| Please circle the appropriate answer for each question. |
| 1. |
Does the member have a clinical diagnosis of alcohol dependence? |
|
|
| |
[If the answer to this question is no, then no further questions required.] |
|
| 2. |
Does clinical evidence indicate that the member will abstain from alcohol consumption for at least 5 days prior to treatment initiation? |
|
|
| |
[If the answer to this question is no, then no further questions required.] |
|
| 3. |
Does the member have a diagnosis of renal failure? |
|
|
| |
[If the answer to this question is yes, then no further questions required.] |
|
| 4. |
Has the member had an inadequate treatment response to a trial of oral or injectable naltrexone at clinically significant dosage and duration? |
|
|
| |
[If the answer to this question is yes, skip to question 6.] |
|
| 5. |
Has therapy with naltrexone been documented to be inappropriate for this member for reasons such as hepatic insufficiency or chronic pain medication use? |
|
|
| 6. |
Will Campral administration be a part of a comprehensive psychosocial treatment program for this member? |
|
|
I affirm that the information given on this form is true and accurate as of this date.
|